| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/2011 | EP2334686A2 Cortistatin analogues and syntheses therof |
| 06/22/2011 | EP2334684A1 Pyrazolopyrimidines and their use for the treatment of cns disorders |
| 06/22/2011 | EP2334683A1 Saturated bicyclic heterocyclic derivatives as smo antagonists |
| 06/22/2011 | EP2334682A1 Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators |
| 06/22/2011 | EP2334681A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
| 06/22/2011 | EP2334680A2 Hcv protease inhibitors |
| 06/22/2011 | EP2334678A1 Morphinan compounds |
| 06/22/2011 | EP2334677A1 Triazolopyridine compounds as pim kinase inhibitors |
| 06/22/2011 | EP2334676A1 Substituted 3 -amin0- 1-0x0 or thioxo-i, 2,5,6,7, 8-hexahydr0-2, 7-naphthyridine-4-carb0nitriles as selective alpha 2b antagonists |
| 06/22/2011 | EP2334675A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors |
| 06/22/2011 | EP2334674A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. |
| 06/22/2011 | EP2334673A1 PYRIDO[3,2-d]PYRIDAZINE-2(1H)-ONE COMPOUNDS AS P38 MODULATORS AND METHODS OF USE THEREOF |
| 06/22/2011 | EP2334672A1 New compounds i |
| 06/22/2011 | EP2334671A1 Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof |
| 06/22/2011 | EP2334670A1 New 2-amidothiadiazole derivatives |
| 06/22/2011 | EP2334668A1 Process for preparing olmesartan medoxomil intermediate |
| 06/22/2011 | EP2334667A1 A process for preparation of rosuvastatin acetonide calcium |
| 06/22/2011 | EP2334666A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/22/2011 | EP2334665A1 Modulators for amyloid beta |
| 06/22/2011 | EP2334664A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 06/22/2011 | EP2334662A1 Pyrine or pyrazine derivatives for treating hcv |
| 06/22/2011 | EP2334659A2 Phenyl malonic acid derivatives |
| 06/22/2011 | EP2334658A2 Ortho-aminoanilides for the treatment of cancer |
| 06/22/2011 | EP2334657A1 Piperazine d3 and 5-ht2a receptor modulators |
| 06/22/2011 | EP2334656A1 Triazole compounds, use thereof, and agents containing same |
| 06/22/2011 | EP2334652A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
| 06/22/2011 | EP2334651A2 Dual-acting antihypertensive agents |
| 06/22/2011 | EP2334644A1 Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors |
| 06/22/2011 | EP2334643A1 Phenethylamide derivatives and their heterocyclic analogues |
| 06/22/2011 | EP2334642A2 Simplified one-pot synthesis of [18f]sfb for radiolabeling |
| 06/22/2011 | EP2334637A1 Novel potassium channel blockers |
| 06/22/2011 | EP2334380A1 Anti-ligands molecules and biological applications |
| 06/22/2011 | EP2334379A2 Host cell kinases as targets for antiviral therapies against hcv infection |
| 06/22/2011 | EP2334378A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 06/22/2011 | EP2334369A2 Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process |
| 06/22/2011 | EP2334324A2 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury |
| 06/22/2011 | EP2334321A2 Analysis of hcv genotypes |
| 06/22/2011 | EP2334319A1 Method for reducing scarring during wound healing using antisense compounds directed to ctgf |
| 06/22/2011 | EP2334308A1 Treating or preventing gout |
| 06/22/2011 | EP2334306A2 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase |
| 06/22/2011 | EP2334305A1 Bioadhesive constructs |
| 06/22/2011 | EP2334304A1 Therapeutic bone growth and regeneration |
| 06/22/2011 | EP2334303A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer |
| 06/22/2011 | EP2334302A2 Dosage forms for weakly ionizable compounds |
| 06/22/2011 | EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
| 06/22/2011 | EP2334300A2 Composition and method for treatment of preterm labor |
| 06/22/2011 | EP2334299A1 Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat |
| 06/22/2011 | EP2334298A2 Novel single unit carbapenem aminoglycoside formulations |
| 06/22/2011 | EP2334297A1 Lofexidine enantiomers for use as a treatment for cns disease and pathologies and its chiral synthesis |
| 06/22/2011 | EP2334296A1 Immunomodulating activities |
| 06/22/2011 | EP2334295A1 Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
| 06/22/2011 | EP2334294A2 Composition for the treatment of alopecia |
| 06/22/2011 | EP2334293A2 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses |
| 06/22/2011 | EP2334292A1 Method of determining a phosphorus binder dosage for a dialysis patient |
| 06/22/2011 | EP2334290A1 Drug delivery system for econazole, moxifloxacin, and rifampicin |
| 06/22/2011 | EP2334289A1 Controlled-release nimesulide composition |
| 06/22/2011 | EP2334288A1 Microencapsulation process with solvent and salt |
| 06/22/2011 | EP2334284A2 Compacted cinacalcet |
| 06/22/2011 | EP2334188A1 Composition and methods for the design and development of metallo-enzyme inhibitors |
| 06/22/2011 | EP2334185A1 Compositions and methods of using (r)-pramipexole |
| 06/22/2011 | EP2334182A1 Method of treating organophosphorous poisoning |
| 06/22/2011 | EP2334181A1 Phthalimide derivative metabotropic glutamate r4 ligands |
| 06/22/2011 | EP2334180A1 Alleviating disorders with combining agents that increase epoxygenated fatty acids and agents that increase camp |
| 06/22/2011 | EP2334178A1 Compositions and methods for the treatment of bowel diseases with granulated mesalamine |
| 06/22/2011 | EP2334176A1 Topical formulations for treatment of neuropathy |
| 06/22/2011 | EP2260026B1 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 06/22/2011 | EP2252591B1 Aryl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 06/22/2011 | EP2231662B1 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents |
| 06/22/2011 | EP2227240B1 Parvovirus cancer therapy and combination with chemotherapy |
| 06/22/2011 | EP2214658B1 Osmolyte-containing preparation for use in case of dry mucous membranes |
| 06/22/2011 | EP2203448B1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical |
| 06/22/2011 | EP2203422B1 Phenylpyrrolidine compounds |
| 06/22/2011 | EP2155674B1 Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands |
| 06/22/2011 | EP2146714B1 Use of 4-cyclopropylmethoxy-<i>n</i>-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease |
| 06/22/2011 | EP2132228B1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 06/22/2011 | EP2120936B1 Novel methods |
| 06/22/2011 | EP2102157B1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/22/2011 | EP2094254B1 Treatment of cachexia |
| 06/22/2011 | EP2054420B1 Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof |
| 06/22/2011 | EP2026799B1 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such |
| 06/22/2011 | EP1994020B1 Substituted quinolones III |
| 06/22/2011 | EP1979334B1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same |
| 06/22/2011 | EP1968951B1 Novel n-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor ccr4. |
| 06/22/2011 | EP1950219B1 Novel dihydropseudoerythromycin derivatives |
| 06/22/2011 | EP1912979B1 Phenyl-{3-(3-(1h-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 06/22/2011 | EP1888624B1 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 06/22/2011 | EP1866318B1 Thienopyridine compounds, and methods of use thereof |
| 06/22/2011 | EP1856110B1 Oxyindole derivatives as 5ht4 receptor agonists |
| 06/22/2011 | EP1827488B1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 06/22/2011 | EP1812004B1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 06/22/2011 | EP1748985B1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 06/22/2011 | EP1668021B1 Novel thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics |
| 06/22/2011 | EP1616856B1 Novel transcriptional factor, process for producing the same and use thereof |
| 06/22/2011 | EP1596872B1 Compositions and methods for restoring bacterial flora |
| 06/22/2011 | EP1587514B3 A rapid-acting pharmaceutical composition |
| 06/22/2011 | EP1546174B1 Methods and compositions for rna interference |
| 06/22/2011 | EP1328545B1 Human gene critical to fertility |
| 06/22/2011 | EP1290161B1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi |
| 06/22/2011 | EP1207876B1 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing |
| 06/22/2011 | CN1985878B Medicine composition for treating peptic ulcer and its preparing method |